4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0000950170-24-113263
President and CEO sold 3,607 shares at $0.88 ($3,172)
From the SEC's structured data for this filing
Trades in this filing
Paulson Richard A. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-04 | Sale : show line 1 in the form | −3,607 | $0.88 | $3,172 | 1,135,607 | D |
| Open-market sales · 3,607 sh · avg $0.88 · $3,172 | ||||||
Loading xslF345X05/ownership.xml…